CANIMGUIDE THERAPEUTICS AB has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are C2N DIAGNOSTICS LLC, SUZHOU LIHAO BIOTECHNOLOGY CO LTD and DMNOMORE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | United States | 9 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Håkansson Leif | 18 |
#2 | Clinchy Birgitta | 13 |
#3 | Hakansson Leif | 9 |
#4 | Haakansson Leif | 2 |
#5 | Ahlqvist Kristofer | 1 |
#6 | Hakansson Annika | 1 |
#7 | Hokansson Leif | 1 |
#8 | Sjödahl Rune | 1 |
#9 | Leif Haakansson | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020069408A1 | Pharmaceutical formulations of peptide inhibitors | |
WO2016144650A1 | Immune system modulators and compositions | |
KR20160054531A | Immune system modulators | |
EP2226334A2 | Immunoregulatory structures from normally occuring proteins | |
EP1875246A1 | Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6 | |
EP1844336A1 | Immunoregulation in cancer, chronic inflammatory and autoimmune diseases | |
EP1507548A1 | Method for determining immune system affecting compounds |